Safety and efficacy of second-line bosutinib for chronic phase chronic myeloid leukemia over a five-year period: final results of a phase 1/2 study.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Jorge Eduardo Cortes Tim H Brümmendorf Hagop Kantarjian Jeff H Lipton Carlo Gambacorti-Passerini Philippe Schafhausen Mark S Shapiro Kay Noonan Nathalie Bardy-Bouxin |
| Publication date | May 17, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |